Edwards Lifesciences (EW) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 01/15/22
EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEPRNewsWire • 01/05/22
EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENTPRNewsWire • 12/20/21
Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement ProgramPRNewsWire • 11/06/21
TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to Surgery in Partner 3 AnalysisPRNewsWire • 11/05/21
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/28/21
Amazon, Mastercard, Pinterest and More Friday Afternoon Analyst Upgrades and Downgrades24/7 Wall Street • 07/30/21
Edwards Lifesciences Beats Q2 Earnings On Demand Recovery, Boosts FY2021 Guidance; Analysts Raise Price TargetBenzinga • 07/30/21
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/30/21